Sarepta Therapeutics Inc SRPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/22/21 EDT
80.40quote price arrow up+0.16 (+0.20%)
Volume
58,269
Close
80.24quote price arrow down-0.68 (-0.84%)
Volume
654,684
52 week range
65.30 - 181.83
Loading...
  • Open80.66
  • Day High81.51
  • Day Low79.05
  • Prev Close80.92
  • 52 Week High181.83
  • 52 Week High Date12/22/20
  • 52 Week Low65.30
  • 52 Week Low Date07/27/21

Key Stats

  • Market Cap6.406B
  • Shares Out79.84M
  • 10 Day Average Volume1.78M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change-52.94

KEY STATS

  • Open80.66
  • Day High81.51
  • Day Low79.05
  • Prev Close80.92
  • 52 Week High181.83
  • 52 Week High Date12/22/20
  • 52 Week Low65.30
  • 52 Week Low Date07/27/21
  • Market Cap6.406B
  • Shares Out79.84M
  • 10 Day Average Volume1.78M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change-52.94

RATIOS/PROFITABILITY

  • EPS (TTM)-8.03
  • P/E (TTM)-10.00
  • Fwd P/E (NTM)-10.98
  • EBITDA (TTM)-585.939M
  • ROE (TTM)-83.05%
  • Revenue (TTM)600.08M
  • Gross Margin (TTM)86.79%
  • Net Margin (TTM)-105.73%
  • Debt To Equity (MRQ)225.31%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous...
M. Kathleen Behrens Ph.D.
Non-Executive Chairman
Douglas Ingram Esq., J.D.
President
Ian Estepan
Chief Financial Officer
Louise Rodino-Klapac Ph.D.
Executive Vice President
William Ciambrone
Executive Vice President
Address
215 1st St Ste 415
Cambridge, MA
02142-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
NVTA
Invitae Corp
27.99-0.23-0.81%
HALO
Halozyme Therapeutics Inc
38.87+0.04+0.10%
CRSP
CRISPR Therapeutics AG
95.56-1.50-1.55%
DNLI
Denali Therapeutics Inc
47.80+1.63+3.53%
RARE
Ultragenyx Pharmaceutical Inc
78.22-0.18-0.23%